NCT04066699View on ClinicalTrials.gov

Percutaneous Localization: Open-label Registry of Thoracic Surgery

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

January 5, 2023

Study Completion Date

February 9, 2023

Conditions
Lung Lesion(s) Requiring EvaluationPulmonary MetastasisPulmonary Nodule, SolitaryPeripheral Lung Lesions
Interventions
PROCEDURE

Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools.

Transthoracic localization of suspicious lung lesion(s) in preparation for subsequent resection.

Trial Locations (5)

12601

Vassar Brothers Medical Center, Poughkeepsie

27599

University of North Carolina at Chapel Hill, Chapel Hill

77030

Houston Methodist Hospital, Houston

80124

Kaiser Permanente, Lone Tree

04401

Northern Light Eastern Maine Medical Center, Bangor

Sponsors
All Listed Sponsors
lead

Veran Medical Technologies

INDUSTRY

NCT04066699 - Percutaneous Localization: Open-label Registry of Thoracic Surgery | Biotech Hunter | Biotech Hunter